Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 98 of 126 for:    "Acute Leukemia" | "Antimetabolites, Antineoplastic"

Palbociclib in Combination With Chemotherapy in Treating Children With Relapsed Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LL)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03792256
Recruitment Status : Recruiting
First Posted : January 3, 2019
Last Update Posted : October 2, 2019
Sponsor:
Information provided by (Responsible Party):
Children's Oncology Group

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : September 30, 2020
Estimated Study Completion Date : September 30, 2020